Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense pruritus, recurrent eczema, and substantial impairment in quality of life (QoL). Affecting up to 20 percent of children and approximately 10 percent of adults in high-income countries, AD places a significant burden on patients and their families, impacting sleep, productivity, and psychosocial well-being. [Br J Dermatol 2021;184:304-309]